Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juni 2020 07:00 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products

Collaboration will enable Pluristem to develop new technologies relying on its PLX platformThe consortium is supported by the Israeli Innovation Authority as part of its Bio-Convergence Program, and...
14. Mai 2020 08:00 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.

87.5% survival rate of patients on invasive mechanical ventilation injected with PLX cells75% of patients no longer in need of any mechanical ventilation 62.5% of the patients discharged alive from...
08. Mai 2020 06:00 ET | Quelle: Pluristem Therapeutics, Inc.

U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study

140 patients with severe COVID-19 and ARDS to be treatedPrimary endpoint: ventilator free days during the main 28-day study period, secondary endpoint includes survival rate and ICU free days HAIFA,...
05. Mai 2020 09:56 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Announces Pricing of Its Registered Direct Offering for Aggregate Proceeds of $15 Million

HAIFA, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic...
30. April 2020 09:30 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Recaps Investor & Analyst Call Reviewing European Investment Bank’s €50 Million Financing

• Elaborating on agreement terms and tranches schedule• Provides update on cash position and clinical program HAIFA, Israel, April 30, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc....
30. April 2020 02:00 ET | Quelle: Pluristem Therapeutics, Inc.

EIB signs collaboration with Israel Innovation Authority and €50 million financing agreement with Pluristem to develop therapies for COVID-19 and other unmet medical needs

HAIFA, Israel, April 30, 2020 (GLOBE NEWSWIRE) -- European Investment Bank (EIB) backs Pluristem with €50 million of financing, which will help the company to advance the clinical...
27. April 2020 06:00 ET | Quelle: Pluristem Therapeutics, Inc.

The European Investment Bank (EIB), EU Delegation to Israel, the Israel Innovation Authority, and Pluristem Cordially Invite the Public to an Online Signing Ceremony on April 30, 2020

HAIFA, Israel, April 27, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic...
24. April 2020 06:00 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Secures €50 Million Non-Dilutive Financing from the European Investment Bank to Support its COVID-19 Project and Phase III Studies

HAIFA, Israel, April 24, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic...
13. April 2020 06:00 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Expands its Compassionate Use Program: Treated First COVID-19 Patient in U.S. Under FDA Single Patient Expanded Access Program

Cleared by FDA to proceed with the treatment in U.S. under Coronavirus Treatment Acceleration Program (CTAP)Pluristem’s main focus: multinational clinical trial of PLX cells for treatment of...
07. April 2020 07:50 ET | Quelle: Pluristem Therapeutics, Inc.

Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure

All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS)100% survival rate for all seven patients6 patients completed 1 week...

Vorherige Seite

Nächste Seite